Literature DB >> 16151023

Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells.

Mohanraj Rajesh1, Antonina Kolmakova, Subroto Chatterjee.   

Abstract

Vascular endothelial growth factor (VEGF) has been implicated in angiogenesis associated with coronary heart disease, vascular complications in diabetes, inflammatory vascular diseases, and tumor metastasis. The mechanism of VEGF-driven angiogenesis involving glycosphingolipids such as lactosylceramide (LacCer), however, is not known. To demonstrate the involvement of LacCer in VEGF-induced angiogenesis, we used small interfering RNA (siRNA)-mediated silencing of LacCer synthase expression (GalT-V) in human umbilical vein endothelial cells. This gene silencing markedly inhibited VEGF-induced platelet endothelial cell adhesion molecule-1 (PECAM-1) expression and angiogenesis. Second, we used D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP), an inhibitor of LacCer synthase and glucosylceramide synthase, that significantly mitigated VEGF-induced PECAM-1 expression and angiogenesis. Interestingly, these phenotypic changes were reversed by LacCer but not by structurally related compounds such as glucosylceramide, digalactosylceramide, and ceramide. In a human mesothelioma cell line (REN) that lacks the endogenous expression of PECAM-1, VEGF/LacCer failed to stimulate PECAM-1 expression and tube formation/angiogenesis. In REN cells expressing human PECAM-1 gene/protein, however, both VEGF and LacCer-induced PECAM-1 protein expression and tube formation/angiogenesis. In fact, VEGF-induced but not LacCer-induced angiogenesis was mitigated by SU-1498, a VEGF receptor tyrosine kinase inhibitor. Also, VEGF/LacCer-induced PECAM-1 expression and angiogenesis was mitigated by protein kinase C and phospholipase A2 inhibitors. These results indicate that LacCer generated in VEGF-treated endothelial cells may serve as an important signaling molecule for PECAM-1 expression and in angiogenesis. This finding and the reagents developed in our report may be useful as anti-angiogenic drugs for further studies in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151023     DOI: 10.1161/01.RES.0000185327.45463.A8

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  23 in total

1.  Poly(ADP-ribose)polymerase inhibition decreases angiogenesis.

Authors:  Mohanraj Rajesh; Partha Mukhopadhyay; Grzegorz Godlewski; Sándor Bátkai; György Haskó; Lucas Liaudet; Pál Pacher
Journal:  Biochem Biophys Res Commun       Date:  2006-10-09       Impact factor: 3.575

2.  Transmembrane BAX inhibitor motif containing (TMBIM) family proteins perturbs a trans-Golgi network enzyme, Gb3 synthase, and reduces Gb3 biosynthesis.

Authors:  Toshiyuki Yamaji; Kiyotaka Nishikawa; Kentaro Hanada
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

3.  Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis.

Authors:  James C Dodge; Christopher M Treleaven; Joshua Pacheco; Samantha Cooper; Channa Bao; Marissa Abraham; Mandy Cromwell; S Pablo Sardi; Wei-Lien Chuang; Richard L Sidman; Seng H Cheng; Lamya S Shihabuddin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

4.  Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor.

Authors:  S Mishra; D Bedja; C Amuzie; C A Foss; M G Pomper; R Bhattacharya; K J Yarema; S Chatterjee
Journal:  Biomaterials       Date:  2015-06-03       Impact factor: 12.479

Review 5.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

6.  Use of a novel anti-proliferative compound coated on a biopolymer to mitigate platelet-derived growth factor-induced proliferation in human aortic smooth muscle cells: comparison with sirolimus.

Authors:  Yong-Dan Tang; Ambarish Pandey; Antonina Kolmakova; Xin-Tong Wang; Subbu S Venkatraman; Subroto Chatterjee; Freddy Y C Boey
Journal:  Glycoconj J       Date:  2008-10-14       Impact factor: 2.916

7.  VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo.

Authors:  Antonina Kolmakova; Mohanraj Rajesh; David Zang; Roberto Pili; Subroto Chatterjee
Journal:  Glycoconj J       Date:  2009-02-14       Impact factor: 2.916

8.  Elastin peptides signaling relies on neuraminidase-1-dependent lactosylceramide generation.

Authors:  Anthony Rusciani; Laurent Duca; Hervé Sartelet; Aurore Chatron-Colliet; Hélène Bobichon; Dominique Ploton; Richard Le Naour; Sébastien Blaise; Laurent Martiny; Laurent Debelle
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

9.  C(6)-Ceramide-Coated Catheters Promote Re-Endothelialization of Stretch-Injured Arteries.

Authors:  Sean M O'Neill; Dina K Olympia; Todd E Fox; J Tony Brown; Thomas C Stover; Kristy L Houck; Ronald Wilson; Peter Waybill; Mark Kozak; Steven W Levison; Norbert Weber; Linda M Karavodin; Mark Kester
Journal:  Vasc Dis Prev       Date:  2008-08-01

10.  Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse.

Authors:  Ying Sun; Huimin Ran; Matt Zamzow; Kazuyuki Kitatani; Matthew R Skelton; Michael T Williams; Charles V Vorhees; David P Witte; Yusuf A Hannun; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.